PER 0.00% 8.0¢ percheron therapeutics limited

DMD results, page-16

  1. 302 Posts.
    lightbulb Created with Sketch. 834
    Comparing Catabasis P2 to ANP’s P2 is like comparing a hyundai to a Ferrari.
    Their data showed the disease progression slowed marginally but our was multiple times better.. examing doctors said the Catabasis’s MRI data “was not quite statistically significant “

    Also, attached is from PPMD comparing Natural History to Placebo.

    https://www.parentprojectmd.org/ctap-study-shows-real-world-natural-history-data-comparable-to-placebo-data-from-trials-in-duchenne/

    Anyone who thinks the data is comparable on any level needs to get themselves to a doctor
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $99.06K 1.226M

Buyers (Bids)

No. Vol. Price($)
1 3500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 40625 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.